This hypothesis was substantiated by in vitro experiments that showed that CASC19 was upregulated in human GC cell lines, and that si-RNA-mediated knockdown inhibited proliferation, anchorage-independent growth, migration, and invasion in the BGC-823 cell line. The gene discussed is CASC19; the disease is gastric cancer.